UPDATE : Thursday, January 24, 2019
상단여백
MSD gains additional indication for Keytruda by Lee Han-soo 2019-01-16 14:01
NK Max submits plans for P1 clinical trial for immunotherapy in US by Lee Han-soo 2019-01-16 11:36
Intra-articular injection Conjuran recognized as new medical tech by Lee Hye-seon 2019-01-15 14:07
Baxter’s dialyzer suspended due to bad-mouthing rival products by Lee Hye-seon 2019-01-15 11:42
Takeda Korea names Moon Hee-seok as new CEO by Lee Han-soo 2019-01-15 11:40
라인
CancerRop secures CAR-T source technology by Lee Han-soo 2019-01-14 15:28
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever by Lee Hye-seon 2019-01-14 14:56
14 drugmakers to release generic copies of Stillen 2X in early February by Lee Hye-seon 2019-01-14 11:34
Dongkoo to test stem cell therapy for diabetic foot ulcers by Lee Hye-seon 2019-01-11 15:53
Pharmaceuticals present future strategy at JP Morgan Healthcare Conference by Lee Han-soo 2019-01-10 18:20
라인
Six Tamiflu takers suffered abnormalities in 5 years by Song Soo-youn 2019-01-10 14:19
Tego Science releases research results for diabetic foot ulcer treatment by Lee Han-soo 2019-01-10 12:48
MSD Korea recalls HIV drug Stocrin with particular code by Lee Hye-seon 2019-01-10 11:46
Pfizer to stop renewing risk-sharing accord for lung cancer drug by Lee Han-soo 2019-01-10 10:40
Hugel wins patent for patch-type BTX product by Lee Han-soo 2019-01-09 16:31
라인
Hanmi to start P1 trial about diabetes combination treatment by Lee Han-soo 2019-01-09 14:51
Pharma Research Bio to start P1 clinical trials about BTX by Lee Han-soo 2019-01-09 14:51
Regulator keeps Kyung Nam Pharm listed with 1-year grace period by Lee Hye-seon 2019-01-09 14:49
Anti-Alzheimer drink Souvenaid mired in illegal ad controversy -- again by Lee Min-ju 2019-01-08 16:10
Handok and Genexine become largest stakeholder of Rezolute by Lee Hye-seon 2019-01-08 14:53
여백
여백
여백
Back to Top